- Home
- INO vs ICCM Comparison
INO vs ICCM Comparison
Compare INO & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- ICCM
- Stock Information
- Founded
- INO 1979
- ICCM 2006
- Country
- INO United States
- ICCM Israel
- Employees
- INO N/A
- ICCM N/A
- Industry
- INO Medical/Dental Instruments
- ICCM
- Sector
- INO Health Care
- ICCM
- Exchange
- INO Nasdaq
- ICCM Nasdaq
- Market Cap
- INO 69.3M
- ICCM 61.1M
- IPO Year
- INO 1998
- ICCM N/A
- Fundamental
- Price
- INO $2.38
- ICCM $0.99
- Analyst Decision
- INO Buy
- ICCM Strong Buy
- Analyst Count
- INO 5
- ICCM 1
- Target Price
- INO $8.80
- ICCM $2.00
- AVG Volume (30 Days)
- INO 2.7M
- ICCM 1.9M
- Earning Date
- INO 11-13-2025
- ICCM 08-13-2025
- Dividend Yield
- INO N/A
- ICCM N/A
- EPS Growth
- INO N/A
- ICCM N/A
- EPS
- INO N/A
- ICCM N/A
- Revenue
- INO $182,337.00
- ICCM $2,787,000.00
- Revenue This Year
- INO N/A
- ICCM $62.11
- Revenue Next Year
- INO $15,775.73
- ICCM $142.91
- P/E Ratio
- INO N/A
- ICCM N/A
- Revenue Growth
- INO N/A
- ICCM N/A
- 52 Week Low
- INO $1.30
- ICCM $0.48
- 52 Week High
- INO $7.00
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- INO 55.04
- ICCM 49.14
- Support Level
- INO $2.33
- ICCM $0.98
- Resistance Level
- INO $2.98
- ICCM $1.12
- Average True Range (ATR)
- INO 0.22
- ICCM 0.07
- MACD
- INO -0.01
- ICCM -0.00
- Stochastic Oscillator
- INO 43.93
- ICCM 11.82
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.